Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 February, 2018 20:27 IST
Lupin launches generic Kapvay tablets in US
Source: IRIS | 08 Feb, 2018, 04.03PM
Comments  |  Post Comment

Pharma major Lupin announced the launch of its Clonidine Hydrochloride extended-release tablets, 0.1mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Clonidine Hydrochloride ER tablets is the generic equivalent of Concordia International Corp's Kapvay tablets. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications.

Kapvay tablets had annual sales of approximately USD 66 million in the US (IQVIA MAT December 2017). 

Shares of the company gained Rs 6.5, or 0.8%, to settle at Rs 814.45. The total volume of shares traded was 154,072 at the BSE (Thursday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
MCX enhances maximum compensation limit to Rs 2.5 mn - 23-Feb-2018 10:31
Dilip Buildcon secures project worth Rs 1.57 bn - 23-Feb-2018 10:17
Reliance Infra wins EPC contract worth Rs 36.47 bn - 23-Feb-2018 10:04
Asset quality improves in microfinance, DeMo blues fade: Crisil - 23-Feb-2018 09:41
Larsen & Toubro bags orders worth Rs 12.66 bn - 23-Feb-2018 09:33
Vascon Engineers inks deal with Lina Ashar Foundation - 22-Feb-2018 13:15
Tata Comm partners with Taiwan's Chunghwa Telecom - 22-Feb-2018 10:57
Godrej Properties adds new residential project in Gurgaon - 22-Feb-2018 10:22
Indian Hume Pipe Co secures work order worth Rs 1.35 bn - 22-Feb-2018 10:15
Glenmark Pharma enters into collaboration with SDC Pharma - 22-Feb-2018 09:39
IRIS Business Services partners with CIPC, South Africa - 22-Feb-2018 09:28
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer